Cargando…

C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy

Detalles Bibliográficos
Autores principales: Shah, Hridaya, Chen, Hang, Pan, Xiang-Zuo, Metjian, Ara, Brodsky, Robert A., Braunstein, Evan M., Chaturvedi, Shruti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713277/
https://www.ncbi.nlm.nih.gov/pubmed/35914225
http://dx.doi.org/10.1182/bloodadvances.2022008395
_version_ 1784841983474270208
author Shah, Hridaya
Chen, Hang
Pan, Xiang-Zuo
Metjian, Ara
Brodsky, Robert A.
Braunstein, Evan M.
Chaturvedi, Shruti
author_facet Shah, Hridaya
Chen, Hang
Pan, Xiang-Zuo
Metjian, Ara
Brodsky, Robert A.
Braunstein, Evan M.
Chaturvedi, Shruti
author_sort Shah, Hridaya
collection PubMed
description
format Online
Article
Text
id pubmed-9713277
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-97132772022-12-06 C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy Shah, Hridaya Chen, Hang Pan, Xiang-Zuo Metjian, Ara Brodsky, Robert A. Braunstein, Evan M. Chaturvedi, Shruti Blood Adv Research Letter The American Society of Hematology 2022-08-03 /pmc/articles/PMC9713277/ /pubmed/35914225 http://dx.doi.org/10.1182/bloodadvances.2022008395 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Shah, Hridaya
Chen, Hang
Pan, Xiang-Zuo
Metjian, Ara
Brodsky, Robert A.
Braunstein, Evan M.
Chaturvedi, Shruti
C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
title C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
title_full C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
title_fullStr C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
title_full_unstemmed C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
title_short C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
title_sort c5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713277/
https://www.ncbi.nlm.nih.gov/pubmed/35914225
http://dx.doi.org/10.1182/bloodadvances.2022008395
work_keys_str_mv AT shahhridaya c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy
AT chenhang c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy
AT panxiangzuo c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy
AT metjianara c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy
AT brodskyroberta c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy
AT braunsteinevanm c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy
AT chaturvedishruti c5inhibitionallowscontinuedantineoplastictherapyincancerandchemotherapyassociatedthromboticmicroangiopathy